Ideas
Aerospace remains a leading Korean theme
Aerospace is continuing as a leading Korean theme, and the speaker groups it with space and defense as part of the global themes still worth trading.
Samsung, SK hynix lead semiconductors
The semiconductor sector is broadly strong. Samsung Electronics and SK hynix are absorbing positive global narratives, making higher lows near highs and leaving recent buyers with little loss. If stock-picking in equipment names is hard, combine Samsung and SK hynix with a Korean semiconductor equipment ETF.
Korean market stays liquidity-driven and strong
The Korean market is the strongest among global markets, driven by ample deposits around KRW 110tn and contained credit around KRW 30tn, so selloffs are not self-reinforcing. The speaker expects a stock-picking market through next week and a stronger rally after the Lunar New Year holiday.
Rare-earth race lifts Korean mineral names
US interest in Greenland and rare earths, plus the global critical-minerals race, is driving Korean mineral names. Korea Zinc is the leading Korean mineral company, while ITCEN Global, JS Link and POSCO International are showing sector action and new highs.
AI power demand boosts nuclear and equipment
AI data centers require massive energy, and the speaker sees nuclear and power equipment as a core theme. Doosan Enerbility and Hyundai Construction are making multi-year highs, while Hyosung Heavy Industries, LS Electric and Sanil Electric are power-equipment beneficiaries.
Resting themes should rotate later
Robots, autonomous driving, semiconductor equipment and bio are resting, but the speaker expects them to rotate later, so investors should keep exposure to these leading themes.
SpaceX listing benefits Korean stake holders
SpaceX is expected to list around June or early H2. Stake-holding beneficiaries such as Mirae Asset Venture Investment and Mirae Asset Securities tend to rally before the date is fixed; even if confirmation causes volatility, the theme can rebound.
Shipbuilding cycle is turning upward
Shipbuilding is starting to turn. Samsung Heavy and Hanwha Ocean earnings are expected to improve, Hanwha Engine is already at new highs, and Taekwang is recovering from the bottom; large-volume bullish candles are a positive hint.
AI disruption hurts software and NAVER
AI agents and client-built software are disrupting traditional software; US and Korean software companies are struggling. NAVER has failed to act as an AI leader and should be avoided for now.
Google capex supports Broadcom TPU demand
Google's strong cloud growth and sharply increased capex, including TPU buildout, should benefit Broadcom. Broadcom had been weak but rebounded with Google's earnings.
AMD guidance and custom chips pressure shares
AMD fell 17% after guidance disappointed relative to its high valuation. Custom AI chips from Google and Microsoft challenge AMD's accelerator expansion, and its chart is broken; chasing it is risky.
Micron chart and valuation look risky
Micron fell about 9%, breaking its technical trend, and its valuation near 40x forward earnings makes indiscriminate chasing risky even though memory demand remains strong.
Korean memory is cheap versus Micron
SK hynix trades below 10x forward earnings versus Micron around 36x. If SK hynix earns KRW 100tn, its roughly KRW 600tn market cap implies less than 10x, so declines are buying opportunities for investors targeting KRW 1m or more.
SanDisk, WDC volatility warns NAND names
SanDisk and Western Digital have extreme volatility after huge gains at a high level. Korean NAND equipment names such as Exicon and Neosem may also be affected, so traders should be cautious.
Apple strength lifts Korean supplier names
Apple is acting as a safe haven with over 50% shareholder returns and benefits from China's trade-in subsidies. Korean Apple suppliers such as Jahwa Electronics are at multi-year highs and can be held while above the 5-day line.
Tesla catalysts support buying on dips
Tesla's China weekly sales rose to about 69k, and Optimus Gen3 or Robotaxi updates are expected between February and March. The speaker says US big-tech dips are opportunities and Tesla is worth waiting for at current levels.
Korean obesity names lag US peers
Korean obesity-related names such as Olix, ABL Bio and D&D Pharmatech are weak because KOSDAQ money is concentrated in large caps, and US obesity strength has not translated into Korean stocks. Treat them separately from US moves.
Samsung Electronics remains undervalued
Samsung Electronics trades at roughly KRW 1,000tn market cap despite potential annual operating profit of KRW 100tn. Foundry losses are narrowing and could turn profitable, and mobile/MWC catalysts could support the stock; the valuation still looks low.
Alphabet beat and capex is sustainable
Alphabet's earnings were strong: revenue exceeded $400bn annualized, Google Cloud grew 48%, EPS beat, capex guidance was raised to $175-185bn, and free cash flow was much better than expected. The market's negative reaction is excessive and the AI cycle remains intact.
Korea decouples from US tech weakness
The US-listed Korea equity ETF fell 3% but recovered to a 1% decline, showing Korea's hardware strength regardless of which AI platform wins. The Korean market is decoupling from US tech weakness and tends to recover quickly.
Memory shortage benefits Samsung, SK hynix
US tech weakness is an opportunity in Korean memory. Morgan Stanley estimates Samsung operating profit at KRW 250tn and SK hynix at KRW 178tn; at 10x P/E, Samsung has roughly 100% upside toward KRW 270k and SK hynix has large upside. Accumulate on dips.
Eli Lilly leads obesity drug growth
Eli Lilly beat estimates with 40%+ revenue and EPS growth, Mounjaro sales up 110% and Zepbound up 123%, and guidance above consensus. Medicare coverage expansion from July could add up to 40m new customers, supporting obesity-drug leadership.
Novo Nordisk loses share to Lilly
Novo Nordisk faces price pressure, intensifying competition, and negative guidance, and it is losing obesity-market share to Eli Lilly. The stock fell sharply and should be avoided.
Reformulation pipelines may draw Novo interest
Novo Nordisk may acquire long-acting or oral formulation platforms to defend its franchise, so Korean obesity and reformulation pipeline names such as Hanmi Pharmaceutical, D&D Pharmatech, Peptron and G2G Bio could attract attention.
Reformulation pipelines may draw Novo interest
Eli Lilly's surge and the launch of obesity generics from this year increase attention on Korean obesity names. Chong Kun Dang Pharm rose despite saying it is not developing an oral treatment, G2G Bio's chart is strong, Hanmi Pharmaceutical broke out, and Peptron/D&D Pharmatech are in the theme.
US supports critical minerals and miners
The US is considering price floors, Project Vault stockpiling, tariffs and direct equity stakes in critical-minerals miners to reduce dependence on China. This supports miners, though government involvement may reduce autonomy; Korean names include JS Link, LS Group and POSCO International.
First US investment may be energy
The first Korean investment project demanded by the US is reported to be in energy, excluding Alaska LNG and nuclear, making ESS, power equipment and solar possible beneficiaries. The details are not yet public, so monitor for confirmation.
Symbotic results lift logistics automation
Symbotic swung to profit and guided above expectations, sending shares up over 12% after hours. The read-through is positive for robotics, logistics automation and smart-factory names.
Agentic AI threatens software business models
Agentic AI tools can now browse, sort files, write code and automate office work, threatening traditional software business models. This uncertainty is pressuring tech and software shares and driving money into other sectors.
Obesity generics lift Korean drugmakers
Eli Lilly's surge and the launch of obesity generics from this year increase attention on Korean obesity names. Chong Kun Dang Pharm rose despite saying it is not developing an oral treatment, G2G Bio's chart is strong, Hanmi Pharmaceutical broke out, and Peptron/D&D Pharmatech are in the theme.
AI power demand favors solar/renewables
AI data-center power demand makes solar and renewables essential because nuclear takes years to build. Hanwha Solutions is a turnaround play with potential KRW 1tn operating profit by 2027, and HD Hyundai Energy Solutions is the theme leader; Musk's China solar meetings added momentum. Buy on pullbacks.
Asset stocks trade on NAV, not earnings
Asset-heavy real-estate and holding names such as Sampyo Cement and Harim Holdings, which is cheap versus its Pan Ocean stake, surged. These stocks trade on PBR/NAV rather than earnings, so breakout entries can work despite valuation concerns.
SK Telecom offers value and dividends
SK Telecom is cheap, pays a large dividend, and has been trending up; after a rest, pullbacks to moving averages can be bought while the uptrend remains intact.
Doosan Enerbility nears breakout level
Doosan Enerbility is testing a box breakout near KRW 95,000-97,000 with strong foreign buying. If it clears prior highs, momentum traders and long-term investors may add, creating upside.
Chips&Media set for box breakout
Chips&Media, an autonomous-driving chip/media name, is breaking out of a box with decent premarket volume. If KOSDAQ is strong, it is a technical long setup.
Medical AI setups offer pullback entries
Medical AI and robotics names are pulling back to moving averages and setting up: Koh Young rose 16% and can be bought near the 10-day line, Curexo is riding the 5-day, and Three Billion is trying to reverse from the 60-day with a risk level near KRW 14,000.
Geopolitical risk supports gold, silver, oil
Iran-related geopolitical risk and stalled nuclear talks are supporting safe havens: gold recovered $5,000/oz, silver rose about 5% toward $90, and oil strengthened. The speaker presents these as supported by risk flows.
US money rotates to energy, materials, transport
US money is rotating out of tech into energy, materials and transportation. XOP hit a new high, materials XLB is rising independently, energy XLE is strong, and transportation IBT reached a new high.
High-multiple tech faces yield pressure
Rising 10-year Treasury yield near 4.3% pressures high-multiple growth stocks. Palantir gave back its post-earnings gain and broke lows, Oracle continues lower, and AI disruption worries weigh on software.
US obesity strength lifts Korean biotech
US healthcare and Eli Lilly strength should keep momentum in obesity treatments, and the speaker lists Korean biotech and obesity-related names such as D&D Pharmatech, Samyang Biopharm, April Bio, Ildong Pharmaceutical, Celltrion Pharm, Aimed Bio, Cellbion and Inventage as market movers.
US solar ETF hits new high
The US solar ETF TAN hit a new high despite Trump, driven by AI data-center power demand, rising electric bills, and residential solar plus ESS adoption. Enphase surged about 40% and Sunrun/SolarEdge were strong.
Consumer retail outperforms; wealth effect supports
Consumer and retail are outperforming tech. Walmart, Starbucks, Nike, Costco and Coca-Cola are strong in the US. In Korea, E-Mart, Shinsegae, Lotte Shopping and Hyundai Department Store benefit from the wealth effect, Chinese tourists, and Lotte Shopping's real-estate asset value.
Hyundai Construction earnings drive upgrades
Hyundai Construction turned to profit and analysts raised target prices to KRW 130k-148k. The stock is strong despite US nuclear weakness, giving it positive relative momentum.
Nexen Tire earnings lift tire sector
Nexen Tire reported good earnings and target prices were broadly raised, making tires a relatively strong auto-related category.
KB sees Samsung earnings beating TSMC
KB Securities maintained a KRW 240k target, forecasting DRAM operating profit up 16x year-on-year and total operating profit of KRW 170tn, more than TSMC. The speaker says numbers will prove the stock.
LigaChem Bio leads bio export hopes
After Alteogen and ABL Bio were hit by negative news, the market expects LigaChem Bio to lead technology-export expectations among large bio names, and it is relatively resilient.
Jahwa offers lower-valuation robot exposure
Robot stocks are correcting, but Jahwa Electronics has actuator technology for humanoid robots and a less demanding valuation. It has shown relative strength and unusual corporate activity since January 29.
This 815 Money Talk (815머니톡) video, published February 05, 2026,
features Hwang Yoo-hyun, Ha Chang-bong, Lee Ju-hyeon, Min Jae-gi
discussing Korean aerospace/defense sector, 005930.KS, 000660.KS, Korean semiconductor equipment ETF, EWY, KOSDAQ, 010130.KS, 124500.KQ, 127120.KQ, 047050.KS, 034020.KS, 000720.KS, 298040.KS, 010120.KS, 062040.KS, Korean Robotics, Autonomous driving, SMH, XBI, 100790.KQ, 006800.KS, 010140.KS, 042660.KS, Hanwha Engine, Taekwang, 035420.KS, IGV, AVGO, AMD, MU, SNDK, WDC, AAPL, 033240.KS, TSLA, Olix, ABL Bio, 347850.KQ, GOOGL, LLY, NVO, 128940.KS, 087010.KQ, 456160.KQ, LS Group, ESS, Power equipment, SOLAR, SYM, Software/SaaS, 185750.KS, 009830.KS, HD Hyundai Energy Solutions, 038500.KQ, 003380.KQ, 017670.KS, 094360.KQ, 098460.KQ, 060280.KQ, 394800.KQ, GLD, SILVER, WTI, XOP, XLB, XLE, IYT, PLTR, ORCL, Samyang biopharm, 397030.KQ, 249420.KS, 068760.KQ, Aimed Bio, Cellbion, 389470.KQ, TAN, ENPH, RUN, WMT, SBUX, NKE, COST, KO, 139480.KS, 004170.KS, 023530.KS, 069960.KS, 002350.KS, 141080.KQ.
47 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Hwang Yoo-hyun,
Ha Chang-bong,
Lee Ju-hyeon,
Min Jae-gi
· Tickers:
Korean aerospace/defense sector,
005930.KS,
000660.KS,
Korean semiconductor equipment ETF,
EWY,
KOSDAQ,
010130.KS,
124500.KQ,
127120.KQ,
047050.KS,
034020.KS,
000720.KS,
298040.KS,
010120.KS,
062040.KS,
Korean Robotics,
Autonomous driving,
SMH,
XBI,
100790.KQ,
006800.KS,
010140.KS,
042660.KS,
Hanwha Engine,
Taekwang,
035420.KS,
IGV,
AVGO,
AMD,
MU,
SNDK,
WDC,
AAPL,
033240.KS,
TSLA,
Olix,
ABL Bio,
347850.KQ,
GOOGL,
LLY,
NVO,
128940.KS,
087010.KQ,
456160.KQ,
LS Group,
ESS,
Power equipment,
SOLAR,
SYM,
Software/SaaS,
185750.KS,
009830.KS,
HD Hyundai Energy Solutions,
038500.KQ,
003380.KQ,
017670.KS,
094360.KQ,
098460.KQ,
060280.KQ,
394800.KQ,
GLD,
SILVER,
WTI,
XOP,
XLB,
XLE,
IYT,
PLTR,
ORCL,
Samyang biopharm,
397030.KQ,
249420.KS,
068760.KQ,
Aimed Bio,
Cellbion,
389470.KQ,
TAN,
ENPH,
RUN,
WMT,
SBUX,
NKE,
COST,
KO,
139480.KS,
004170.KS,
023530.KS,
069960.KS,
002350.KS,
141080.KQ
